Spotted: Celebrating scrutiny; impact detractor
Highlighting retractions can keep researchers in check, and a top journal editor wants to rethink ‘impact.’
A roundup of autism papers and media mentions you may have missed.
Highlighting retractions can keep researchers in check, and a top journal editor wants to rethink ‘impact.’
Nobel Laureate Tim Hunt resigns after ranting about women in labs, and American scientists blow $28 billion a year on research that can’t be replicated.
A rat study bolsters the ‘intense world theory’ of autism, and the stats around CRISPR will astound you.
Ecstasy may ease social anxiety in autism, and ethical lapses reveal dangerous gaps in medical research oversight.
The world’s most populous country takes stock of autism, and guinea pigs ease anxiety in children with the disorder.
This sweet story behind optogenetics will inspire you, and autism experts swarm Salt Lake City.
A sexist peer review sparks a Twitter firestorm, and business is booming for some firms that employ people with autism.
Peer review panels really can suss out good science, and clinical trials could get extremely personal.
Newt Gingrich wants to double spending on medical research, and Chinese researchers highlight the hazards of editing human genomes.
A biotech breakthrough sparks a high-stakes patent war, and two new films follow people with autism looking for love.